MOCS2 and metabolic disease: Routine and extended screening for metabolic disorders yielded no positive results; WES was ordered to determine any genetic abnormalities that revealed a MoCS2 mutation, confirming MoCD type B. Exome sequencing as a first‐line diagnostic tool in this patient profile enables accurate diagnosis that could impact family planning, even in previous pregnancies.